Purple Biotech (PPBT) Invested Capital (2014 - 2026)

Purple Biotech (PPBT) has 13 years of Invested Capital data on file, last reported at $9.7 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $9.7 million, down 70.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.7 million (down 70.44% YoY), and the FY2025 annual result was $9.7 million, down 70.65% from the prior year.
• Invested Capital steadied at $9.7 million in Q1 2026 per PPBT's latest filing, from $9.7 million in the prior quarter.
• Over five years, Invested Capital peaked at $132.2 million in Q2 2023 and troughed at $9.7 million in Q4 2025.
• A 5-year average of $45.6 million and a median of $32.9 million in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2024: Invested Capital surged 73.24% in 2022, then tumbled 77.79% in 2024.
• A 5-year view of Invested Capital shows it stood at $47.1 million in 2022, then retreated by 27.18% to $34.3 million in 2023, then declined by 4.04% to $32.9 million in 2024, then sank by 70.65% to $9.7 million in 2025, then advanced by 0.05% to $9.7 million in 2026.
• Business Quant data shows PPBT's Invested Capital at $9.7 million in Q1 2026, $9.7 million in Q4 2025, and $32.8 million in Q3 2025.